Welcome to our dedicated page for Suro Capital SEC filings (Ticker: SSSSL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Suro Capital's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Suro Capital's regulatory disclosures and financial reporting.
SuRo Capital Corp. director Ronald M. Lott reported an open-market sale of common stock by the Ronald M. Lott Family Trust, an entity associated with him. The trust sold 10,669 shares at a weighted-average price of $12.90 per share. Lott may be deemed a beneficial owner of these trust shares but disclaims ownership beyond his pecuniary interest. Following the transactions, he also holds 7,812 shares directly, including restricted shares granted under SuRo Capital’s equity incentive plan that fully vest on the earlier of May 28, 2026 or the company’s next annual meeting closest to that date.
SuRo Capital Corp. director Ronald M. Lott reported an open-market sale of common stock by the Ronald M. Lott Family Trust, an entity associated with him. The trust sold 10,669 shares at a weighted-average price of $12.90 per share. Lott may be deemed a beneficial owner of these trust shares but disclaims ownership beyond his pecuniary interest. Following the transactions, he also holds 7,812 shares directly, including restricted shares granted under SuRo Capital’s equity incentive plan that fully vest on the earlier of May 28, 2026 or the company’s next annual meeting closest to that date.
SuRo Capital Corp. is asking stockholders to vote at its 2026 annual meeting on re-electing two directors, an advisory say-on-pay proposal, and ratifying CBIZ CPAs P.C. as auditor for the year ending December 31, 2026.
The proxy also highlights a planned Externalization under which SuRo Capital will transition to an externally managed structure, enter an advisory agreement with Neostellar Advisors LLC, receive a committed $20,000,000 investment from a Magnetar affiliate, and later change its name to Neostellar Capital Corp. These changes will be decided at a separate special meeting, not at the annual meeting.
SuRo Capital Corp. is asking stockholders to vote at its 2026 annual meeting on re-electing two directors, an advisory say-on-pay proposal, and ratifying CBIZ CPAs P.C. as auditor for the year ending December 31, 2026.
The proxy also highlights a planned Externalization under which SuRo Capital will transition to an externally managed structure, enter an advisory agreement with Neostellar Advisors LLC, receive a committed $20,000,000 investment from a Magnetar affiliate, and later change its name to Neostellar Capital Corp. These changes will be decided at a separate special meeting, not at the annual meeting.
Goldman Sachs & Co. LLC submitted a Form 144 notice reporting proposed sales of restricted stock units acquired as compensation. The filing lists specific grant dates and amounts, including 6,082 units (acquired 05/31/2024) and 4,548 units (acquired 06/05/2025), plus smaller grant line items dated 09/30/2021, 12/30/2021, and 12/20/2018.
The form records the broker as Goldman Sachs & Co. LLC and contains administrative sale-transaction fields; the filing does not state aggregate proceeds, offering mechanics, or timing for completed sales.
Goldman Sachs & Co. LLC submitted a Form 144 notice reporting proposed sales of restricted stock units acquired as compensation. The filing lists specific grant dates and amounts, including 6,082 units (acquired 05/31/2024) and 4,548 units (acquired 06/05/2025), plus smaller grant line items dated 09/30/2021, 12/30/2021, and 12/20/2018.
The form records the broker as Goldman Sachs & Co. LLC and contains administrative sale-transaction fields; the filing does not state aggregate proceeds, offering mechanics, or timing for completed sales.
SURO CAPITAL CORP. Chairman, CEO and President Mark D. Klein reported two open-market purchases of the company’s common stock. He bought 2,500 shares on April 21, 2026 at $13.08 per share and 2,500 shares on April 22, 2026 at $13.25 per share.
After these transactions, he directly beneficially owned 1,676,021 shares of common stock, a total that includes 811,646 shares owned by his spouse and multiple restricted share grants that are subject to vesting under SuRo Capital’s equity incentive plans.
SURO CAPITAL CORP. Chairman, CEO and President Mark D. Klein reported two open-market purchases of the company’s common stock. He bought 2,500 shares on April 21, 2026 at $13.08 per share and 2,500 shares on April 22, 2026 at $13.25 per share.
After these transactions, he directly beneficially owned 1,676,021 shares of common stock, a total that includes 811,646 shares owned by his spouse and multiple restricted share grants that are subject to vesting under SuRo Capital’s equity incentive plans.
SuRo Capital Corp. is proposing a major shift to an external management structure through a joint venture with Magnetar while reporting a sharp rise in net asset value. The company estimates net asset value as of March 31, 2026 at $14.00–$14.50 per share, up from $8.09 at December 31, 2025 and $6.66 at March 31, 2025.
The Board unanimously approved an externalization plan under which Neostellar Advisors LLC, jointly owned by certain SuRo employees and Magnetar, would become investment adviser, subject to stockholder approval. Magnetar will commit $20 million to the company, either as common stock in connection with a qualifying fundraising or via a convertible note.
The new Advisory Agreement includes a 1.75% base management fee on gross assets and a 20% incentive fee over a 7% hurdle, but no incentive fees on existing investments. Based on 2025 figures, total expenses are projected to decline from 4.98% to 4.21% of average total assets, an expected annual savings of 0.77% of assets. SuRo Capital also reports approximately $46.0 million of liquid assets and 25,387,393 shares outstanding as of March 31, 2026, and expects to release full first-quarter results in May 2026.
SuRo Capital Corp. is proposing a major shift to an external management structure through a joint venture with Magnetar while reporting a sharp rise in net asset value. The company estimates net asset value as of March 31, 2026 at $14.00–$14.50 per share, up from $8.09 at December 31, 2025 and $6.66 at March 31, 2025.
The Board unanimously approved an externalization plan under which Neostellar Advisors LLC, jointly owned by certain SuRo employees and Magnetar, would become investment adviser, subject to stockholder approval. Magnetar will commit $20 million to the company, either as common stock in connection with a qualifying fundraising or via a convertible note.
The new Advisory Agreement includes a 1.75% base management fee on gross assets and a 20% incentive fee over a 7% hurdle, but no incentive fees on existing investments. Based on 2025 figures, total expenses are projected to decline from 4.98% to 4.21% of average total assets, an expected annual savings of 0.77% of assets. SuRo Capital also reports approximately $46.0 million of liquid assets and 25,387,393 shares outstanding as of March 31, 2026, and expects to release full first-quarter results in May 2026.
SURO CAPITAL CORP. executive James Robert Nash, the company’s Chief Compliance Officer, filed an initial Form 3 ownership report. The data provided shows no reported buy or sell transactions, and no derivative positions or other holdings information is included in this snapshot.
SURO CAPITAL CORP. executive James Robert Nash, the company’s Chief Compliance Officer, filed an initial Form 3 ownership report. The data provided shows no reported buy or sell transactions, and no derivative positions or other holdings information is included in this snapshot.
SuRo Capital Corp. filed its annual report detailing operations as an internally managed business development company focused on late-stage, venture-backed private companies. The firm seeks capital gains from equity and equity-related investments and has elected to be regulated as both a BDC and a RIC.
As of December 31, 2025, total investments were valued at $225.5 million, up from $209.4 million a year earlier. Private portfolio companies represented 98.1% of the portfolio, with preferred stock of $169.6 million and common stock of $46.7 million. Publicly traded holdings declined to 1.9% of the portfolio.
Net asset value per share was $8.09 on December 31, 2025. The last reported share price on March 10, 2026 was $9.68. The aggregate market value of common stock held by non‑affiliates was $179.9 million on June 30, 2025, based on an $8.21 share price, and there were 25,387,756 shares outstanding as of March 10, 2026.
SuRo Capital Corp. filed its annual report detailing operations as an internally managed business development company focused on late-stage, venture-backed private companies. The firm seeks capital gains from equity and equity-related investments and has elected to be regulated as both a BDC and a RIC.
As of December 31, 2025, total investments were valued at $225.5 million, up from $209.4 million a year earlier. Private portfolio companies represented 98.1% of the portfolio, with preferred stock of $169.6 million and common stock of $46.7 million. Publicly traded holdings declined to 1.9% of the portfolio.
Net asset value per share was $8.09 on December 31, 2025. The last reported share price on March 10, 2026 was $9.68. The aggregate market value of common stock held by non‑affiliates was $179.9 million on June 30, 2025, based on an $8.21 share price, and there were 25,387,756 shares outstanding as of March 10, 2026.
SuRo Capital Corp. reported stronger results for 2025, with net asset value rising to $8.09 per share as of December 31, 2025, up from $6.68 a year earlier, driven by investment gains. Net assets totaled about $205.3 million and the investment portfolio’s fair value was approximately $225.5 million across 35 companies, with the top five holdings representing 54% of portfolio value.
Management highlighted 2026 portfolio company financings that, if completed and assuming other valuations remain unchanged, are expected to add an estimated $5.00–$6.50 per share to current net asset value, which is not yet reflected in the year-end figure. For 2025, the company recorded a net investment loss of $16.5 million, but realized gains of $33.2 million and net unrealized appreciation of $32.1 million produced a $48.8 million increase in net assets from operations, or $2.01 per basic share. SuRo Capital ended 2025 with about $50.1 million of liquid assets, paid cash dividends of $0.50 per share in total during the year, and continued to reduce debt by repurchasing 6.00% Notes due 2026, with $39.2 million in aggregate principal amount bought back by year-end.
SuRo Capital Corp. reported stronger results for 2025, with net asset value rising to $8.09 per share as of December 31, 2025, up from $6.68 a year earlier, driven by investment gains. Net assets totaled about $205.3 million and the investment portfolio’s fair value was approximately $225.5 million across 35 companies, with the top five holdings representing 54% of portfolio value.
Management highlighted 2026 portfolio company financings that, if completed and assuming other valuations remain unchanged, are expected to add an estimated $5.00–$6.50 per share to current net asset value, which is not yet reflected in the year-end figure. For 2025, the company recorded a net investment loss of $16.5 million, but realized gains of $33.2 million and net unrealized appreciation of $32.1 million produced a $48.8 million increase in net assets from operations, or $2.01 per basic share. SuRo Capital ended 2025 with about $50.1 million of liquid assets, paid cash dividends of $0.50 per share in total during the year, and continued to reduce debt by repurchasing 6.00% Notes due 2026, with $39.2 million in aggregate principal amount bought back by year-end.